Absci Corporation (ABSI)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 16
in 67 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About Absci Corporation
Absci Corporation develops potential biologic medicines and cell lines for manufacturing in the United States as a small-cap biotechnology company listed on NASDAQ under the ticker ABSI. Its work centers on potential biologic medicines and the cell lines used in manufacturing them, and the company was founded in 2011.
Today's Snapshot
ABSI closed 2.9% lower at 8.65.
Trading Volume
Below 10d avg (2.9M)
2M
vs S&P 500 Today
Underperforming Market
-2.44%
Updated: September 10, 2026 at 12:18 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$6.01 - $8.94Buy
- RSI (14)46.59Neutral
- Stochastic %K (14, 3, 3)25.95Neutral
- MACD Level (12, 26)-0.01Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.